Promethera Biosciences Alternatives & Competitors

12 companies similar to Promethera Biosciences — Innovative biopharmaceuticals harnessing healthy human liver cells to treat live...

HepaTx Corporation

Off-the-shelf cell therapies for liver disease

3 Seed $250.00K

Palo Alto, United States

Biotechnology Health and Wellness

DiscGenics

REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN

40 Series C $65.80M

Salt Lake City, United St...

Biotechnology Health Care +2

Calluna Pharma

Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...

27 Series A $75.00M

Oslo, Norway

Biotechnology Pharmaceutical

TC BioPharm

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

51 Post-IPO Equity $46.61M

United Kingdom

Biotechnology Health Care +1

Track all Promethera Biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

HepaRegeniX GmbH

Unlocking liver regeneration - delivering recovery

15 $57.69M

Tubingen, Germany

Biotechnology Health Care +2

InGeneron

Unlocking Regenerative Cell Therapy

18 Venture round $52.75M

Houston, United States

Biotechnology Health Care +1

Minerva Biotechnologies

We see the future first

17 $61.30M

Waltham, United States

Biotechnology Health Care +1

Heartseed Inc.

Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...

21 IPO $184.62M

Japan

Biotechnology Care Economy +3

Solu Therapeutics

Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...

23 Series A $72.00M

Boston, United States

Biotechnology Health and Wellness

Brainstorm Cell Therapeutics

36 Post-IPO Equity $63.13M

Israel

Biotechnology Health Care +1

NOVADIP Biosciences S.A.

Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration tec...

58 Series B $87.00M

Belgium

Biotechnology Health Care +1

Taiga Biotechnologies

Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...

1 Seed $46.93M

Aurora, United States

Biotechnology Health and Wellness +1

About Promethera Biosciences

Promethera Biosciences is a biopharmaceutical firm founded in 2009 with a mission to harness healthy human liver cells to develop innovative treatments for liver diseases. The company, originating from the Université Catholique de Louvain, focuses on crafting advanced treatments utilizing allogeneic adult stem cell tec...

Business keywords

Biopharmaceuticals, Cell Therapy, Liver Diseases, Stem Cell Technology, Regenerative Medicine, Chronic Liver Disease, NASH, ACLF, Fatty Liver, Clinical Stage, Liver-based Genetic Diseases, Innovative Treatments, Acquired Liver Diseases, Antibodies

Frequently Asked Questions

Companies similar to Promethera Biosciences include HepaTx Corporation, DiscGenics, Calluna Pharma, TC BioPharm , HepaRegeniX GmbH. They work in Biotechnology and Health and Wellness and share Promethera Biosciences's focus on regenerative medicine, cell therapy and biopharmaceuticals.

Bounce Watch lists 12 companies that share Promethera Biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Promethera Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Promethera Biosciences Profile HepaTx Corporation Alternatives DiscGenics Alternatives Calluna Pharma Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Promethera Biosciences on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.